-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Glycoprotein 276-286
Category | Arenavirus |
CAS | 160543-97-5 |
Description | Glycoprotein (276-286) is a Db-restricted peptide derived from lymphocytic choriomeningitis virus (LCMV) glycoprotein (GP) and corresponds to amino acids 276-286. |
Product Information
Synonyms | L-Leucine, L-serylglycyl-L-valyl-L-α-glutamyl-L-asparaginyl-L-prolylglycylglycyl-L-tyrosyl-L-cysteinyl-; Ser-Gly-Val-Glu-Asn-Pro-Gly-Gly-Tyr-Cys-Leu |
Molecular Weight | 1095.18 |
Molecular Formula | C46H70N12O17S |
Boiling Point | 1664.8±65.0°C (Predicted) |
Purity | ≥95% |
Density | 1.378±0.06 g/cm3 (Predicted) |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Store at -20°C |
Target | Arenavirus |